MetLife Investment Management, LLC

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1529735 Whippany, NJ

Position in LENZ

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$89,551

-$67,041 QoQ

Shares Held

9,787

0.0% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MetLife Investment Management, LLC holds $374,503,407 across 207 Biotechnology names. LENZ ranks #196 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	70,804	$31,616,818
2	PRAX	Praxis Precision Medicines, Inc.	80,930	$26,074,836
3	AXSM	Axsome Therapeutics, Inc.	152,645	$25,800,057
4	HALO	Halozyme Therapeutics, Inc.	374,931	$24,231,790
5	REGN	Regeneron Pharmaceuticals, Inc.	23,567	$18,208,806
6	FTRE	Fortrea Holdings Inc.	1,805,184	$17,004,833
7	ADMA	Adma Biologics, Inc.	1,738,062	$15,659,938
8	VRDN	Viridian Therapeutics, Inc.DE	708,527	$13,858,788

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$89,551	9,787	0.0%	Shares	Defined	2026-05-14
2025-12-31	$156,592	9,787	0.0%	Shares	Defined	2026-02-12
2025-09-30	$455,878	9,787	-10.5%	Shares	Defined	2025-11-13
2025-06-30	$320,651	10,940	+42.8%	Shares	Defined	2025-08-13
2025-03-31	$196,912	7,659	-0.2%	Shares	Defined	2025-05-14
2024-12-31	$221,490	7,672	0.0%	Shares	Defined	2025-02-13
2024-09-30	$182,133	7,672	—	Shares	Defined	2024-11-13
No filing history on record for this holder in this stock.